Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
TOUR Tuniu
- 0.9124
- -0.0296-3.14%
Close May 5 16:00 ET
- 0.9124
- 0.00000.00%
Post 20:01 ET
105.86MMarket Cap10.49P/E (TTM)
0.9311High0.9124Low50.81KVolume0.9300Open0.9420Pre Close47.20KTurnover0.18%Turnover Ratio10.49P/E (Static)116.03MShares1.700552wk High0.71P/B25.20MFloat Cap0.686052wk Low--Dividend TTM27.62MShs Float24.1453Historical High--Div YieldTTM1.99%Amplitude0.4401Historical Low0.9290Avg Price1Lot Size
Tuniu Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -58.65%96.28M | 262.83%232.84M | 36.83%-142.99M | 82.76%-226.34M | -990.07%-1.31B | -144.93%-120.46M | 164.04%268.09M | 81.31%-418.65M | -335.07%-2.24B | -89.87%-514.74M |
| Net income from continuing operations | 182.79%83.7M | 50.20%-101.1M | -58.01%-203M | 90.44%-128.47M | -84.21%-1.34B | -265.84%-729.38M | 74.15%-199.37M | 68.16%-771.32M | -65.20%-2.42B | -227.40%-1.47B |
| Operating gains losses | -274.01%-26.44M | 123.14%15.2M | -1,638.17%-65.67M | -110.26%-3.78M | 4,546.01%36.81M | -106.00%-828K | 1,017.17%13.8M | -85.39%1.24M | -92.06%8.46M | 3,715.16%106.48M |
| Depreciation and amortization | -42.28%17.14M | -22.22%29.69M | -40.19%38.16M | -71.44%63.81M | -30.75%223.39M | 46.52%322.57M | 2.02%220.16M | 2.00%215.8M | 146.44%211.57M | 624.30%85.85M |
| Deferred tax | 4.06%-779K | 53.36%-812K | 26.91%-1.74M | 72.92%-2.38M | -222.59%-8.8M | -15.45%-2.73M | -2.07%-2.36M | 0.34%-2.31M | -119.68%-2.32M | ---1.06M |
| Other non cash items | ---500K | ---- | 15.12%-3.05M | 34.01%-3.6M | -1,684.59%-5.45M | 106.56%344K | -194.08%-5.24M | 554.86%5.57M | ---1.23M | ---- |
| Change In working capital | -85.73%22.3M | 999.81%156.26M | 110.54%14.21M | 87.11%-134.76M | -2,324.53%-1.05B | -75.33%47.01M | 1,674.01%190.53M | 92.29%-12.11M | -122.58%-156.93M | 465.43%695.13M |
| -Change in receivables | 5.26%-8.49M | 68.17%-8.97M | -158.55%-28.17M | -77.90%48.12M | 4,264.65%217.73M | 85.15%-5.23M | -114.99%-35.19M | 145.43%234.73M | -268.50%-516.69M | -1,905.09%-140.22M |
| -Change in prepaid assets | 110.01%6.29M | -229.41%-62.84M | -72.27%48.56M | -60.85%175.14M | 179.22%447.33M | 8,680.88%160.21M | -100.27%-1.87M | 282.12%691.93M | 36.04%-379.92M | -106.38%-593.97M |
| -Change in payables and accrued expense | -92.14%3.31M | 100.45%42.04M | 108.08%20.97M | 64.73%-259.46M | -894.70%-735.54M | -118.02%-73.95M | 224.52%410.38M | -55.57%-329.58M | -116.95%-211.86M | 561.12%1.25B |
| -Change in other current assets | 18.54%41.82M | 1,569.47%35.28M | 134.88%2.11M | 86.61%-6.06M | -44,015.53%-45.23M | 100.40%103K | -164.85%-25.61M | -103.35%-9.67M | 190.77%288.46M | -2,276.07%-317.78M |
| -Change in other current liabilities | 78.75%-4.37M | -62.10%-20.55M | 46.08%-12.68M | 5.91%-23.51M | 68.22%-24.98M | -1,523.02%-78.62M | -32.93%-4.84M | 33.58%-3.64M | -149.46%-5.49M | --11.09M |
| -Change in other working capital | -109.49%-16.25M | 1,132.59%171.3M | 75.95%-16.59M | 92.38%-68.98M | -2,134.06%-905.12M | 129.21%44.5M | 74.44%-152.34M | -189.13%-595.88M | 37.48%668.57M | 100.88%486.3M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -58.65%96.28M | 262.83%232.84M | 36.83%-142.99M | 82.76%-226.34M | -990.07%-1.31B | -144.93%-120.46M | 164.04%268.09M | 81.31%-418.65M | -335.07%-2.24B | -89.87%-514.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -34.86%26.66M | 178.97%40.93M | -107.36%-51.83M | -39.28%703.83M | 300.48%1.16B | -475.43%-578.13M | -74.98%153.99M | 122.56%615.55M | -42.48%-2.73B | -740.27%-1.92B |
| Net PPE purchase and sale | -20.69%-11.81M | -51.75%-9.79M | 56.25%-6.45M | 47.96%-14.74M | 76.87%-28.33M | -2.54%-122.48M | 25.58%-119.44M | -36.14%-160.5M | 24.10%-117.89M | -207.16%-155.32M |
| Net business purchase and sale | -320.44%-7.15M | 120.19%3.24M | ---16.07M | --0 | 269.39%56.26M | -7,416.30%-33.22M | 509.01%454K | 99.33%-111K | 72.57%-16.5M | ---60.15M |
| Net investment purchase and sale | 210.60%31.61M | 64.61%-28.58M | -109.54%-80.76M | -4.86%846.85M | 319.32%890.13M | -128.45%-405.86M | 298.93%1.43B | 115.50%357.62M | -230.80%-2.31B | -389.25%-697.56M |
| Net other investing changes | -92.89%5.39M | 47.79%75.84M | 138.22%51.31M | -155.71%-134.26M | 1,553.23%241M | 98.56%-16.58M | -375.65%-1.15B | 245.95%418.54M | 71.38%-286.76M | -2,781.37%-1B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -34.86%26.66M | 178.97%40.93M | -107.36%-51.83M | -39.28%703.83M | 300.48%1.16B | -475.43%-578.13M | -74.98%153.99M | 122.56%615.55M | -42.48%-2.73B | -740.27%-1.92B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -227.65%-73.98M | -4,545.88%-22.58M | 99.86%-486K | -64.43%-344.56M | -143.20%-209.55M | 434.07%485.11M | 81.50%-145.21M | -121.64%-784.77M | 20.67%3.63B | 95.13%3.01B |
| Net issuance payments of debt | 91.36%-1.97M | -4,186.28%-22.8M | 99.84%-532K | -85.15%-343.03M | -133.56%-185.28M | 182.60%552.12M | --195.37M | ---- | --0 | ---15M |
| Net common stock issuance | ---44.89M | --0 | --0 | ---- | 97.73%-308K | 90.26%-13.55M | 16.30%-139.07M | -105.10%-166.15M | 33.98%3.26B | 58.01%2.43B |
| Proceeds from stock option exercised by employees | 233.33%30K | -80.43%9K | -87.67%46K | 543.10%373K | -46.79%58K | -97.62%109K | -93.19%4.59M | 693.87%67.34M | -32.87%8.48M | 441.20%12.64M |
| Net other financing activities | -12,726.51%-27.15M | --215K | ---- | 92.08%-1.9M | 55.16%-24.02M | 74.01%-53.57M | 69.96%-206.1M | -289.26%-685.96M | -37.29%362.45M | --577.98M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -227.65%-73.98M | -4,545.88%-22.58M | 99.86%-486K | -64.43%-344.56M | -143.20%-209.55M | 434.07%485.11M | 81.50%-145.21M | -121.64%-784.77M | 20.67%3.63B | 95.13%3.01B |
| Net cash flow | ||||||||||
| Beginning cash position | 124.82%444.89M | -49.98%197.89M | 49.79%395.6M | -57.57%264.1M | -25.09%622.52M | 44.30%831.03M | -52.40%575.91M | -50.42%1.21B | 67.40%2.44B | 247.57%1.46B |
| Current changes in cash | -80.51%48.96M | 228.61%251.19M | -246.93%-195.31M | 136.56%132.92M | -70.32%-363.6M | -177.11%-213.49M | 147.10%276.87M | 56.16%-587.86M | -332.85%-1.34B | -44.69%575.94M |
| Effect of exchange rate changes | 33.36%-2.79M | -73.94%-4.19M | -68.49%-2.41M | -127.53%-1.43M | 4.28%5.19M | 122.86%4.97M | 52.73%-21.75M | -141.59%-46.03M | 63.78%110.65M | 2,312.91%67.56M |
| End cash Position | 10.38%491.07M | 124.82%444.89M | -49.98%197.89M | 49.79%395.6M | -57.57%264.1M | -25.09%622.52M | 44.30%831.03M | -52.40%575.91M | -42.42%1.21B | 44.14%2.1B |
| Free cash flow | -62.13%84.47M | 249.26%223.05M | 38.01%-149.44M | 82.03%-241.08M | -452.17%-1.34B | -263.43%-242.94M | 125.67%148.65M | 75.43%-579.15M | -251.73%-2.36B | -108.32%-670.21M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
